Advertisement
Loading...

Belite Bio, Inc

BLTE•NASDAQ
Healthcare
Biotechnology
$144.05
$-9.47(-6.17%)
U.S. Market is Open • 15:42

Belite Bio, Inc (BLTE) Stock Overview

Explore Belite Bio, Inc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap6B
P/E Ratio-65.27
EPS (TTM)$-2.31
ROE-0.23%
Fundamental Analysis

AI Price Forecasts

1 Month$184.81
3 Months$166.18
1 Year Target$139.35

BLTE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Belite Bio, Inc (BLTE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 37.83, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $139.35.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -65.27 and a market capitalization of 6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.33%
5-Day Change
-4.19%
1-Month Change
-12.78%
3-Month Change
-14.44%
6-Month Change
28.47%
Year-to-Date (YTD) Change
-6.26%
1-Year Change
143.43%
3-Year Change
538.09%
5-Year Change
1315.96%
All-Time (Max) Change
1315.96%

Contact Information

https://belitebio.com
858-246-6240
5820 Oberlin Drive, San Diego, CA, 92121

Company Facts

25 Employees
IPO DateApr 29, 2022
CountryUS
Actively Trading

Frequently Asked Questions